Academic Journal

Neonatal Screening for Sickle Cell Disease in Western Andalusia: Results and Lessons Learnt after 3 Years of Implementation

التفاصيل البيبلوغرافية
العنوان: Neonatal Screening for Sickle Cell Disease in Western Andalusia: Results and Lessons Learnt after 3 Years of Implementation
المؤلفون: Núñez-Jurado, David, Payán-Pernía, Salvador, Álvarez-Ríos, Ana I., Jiménez-Jambrina, Margarita, Concepcion Pérez-De-Soto, Inmaculada, José Palma-Vallellano, Antonio, Zapata-Bautista, Rocío, Carlos Hernández-Castellet, José, Paz Garrastazul-Sánchez, Mari, Arqueros-Martínez, Víctor, Urbano-Ramos, María del Mar, Abdelkader-Maanan, Mohamed, Raúl García-Lozano, José, Delgado-Pecellín, Carmen
المصدر: American Journal of Perinatology ; volume 41, issue S 01, page e893-e900 ; ISSN 0735-1631 1098-8785
بيانات النشر: Georg Thieme Verlag KG
سنة النشر: 2022
الوصف: Objective The aim of this study was to present the results obtained in the Newborn Screening Program (NSP) for sickle cell disease (SCD) in western Andalusia and the autonomous city of Ceuta in the first 3 years of implementation, and to describe the discrepancies found in the diagnosis of hemoglobinopathies between the screening method and the confirmatory tests. Study Design A descriptive and retrospective study was carried out, and the findings obtained in the newborns included in the NSP between November 2018 and December 2021 were analyzed. Results A total of 111,205 samples were screened by high-performance liquid chromatography (HPLC). The birth prevalence of SCD, sickle cell trait, hemoglobin C carriers, and the compound heterozygosity Hb C/β-thalassemia was 1/12,356, 1/467, 1/1,278, and 1/55,602 newborns, respectively. Although there was a correlation between the first-line HPLC screening technique (VARIANTnbs HPLC analyzer, Bio-Rad) and the confirmatory tests in most cases, major discrepancies were found in detecting carriers of G-Philadelphia, D, E, and O-Arab hemoglobin variants, with the former having an incidence of 1/10,110 and the others 1/22,241. The carrier status of Hb G-Philadelphia produced an FAD pattern on the screening method that could be mistaken as Hb D, while Hb O-Arab was identified as an FA5 pattern. Hb D was initially recognized as Hb D in two cases. Conclusion An NSP requires at least two different combined methods in order to identify the hemoglobin variant with sufficient certainty. Furthermore, even though software solutions for HPLC suggest a pattern, it must be confirmed with another technique to obtain a correct interpretation of the chromatograms. Key Points
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1055/s-0042-1759646
DOI: 10.1055/s-0042-1759646.pdf
الاتاحة: http://dx.doi.org/10.1055/s-0042-1759646
http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0042-1759646.pdf
رقم الانضمام: edsbas.2FC1AA6C
قاعدة البيانات: BASE